Rebecca Hoffman, MD | |
1300 Elmwood Ave, Wilmette, IL 60091-1649 | |
(847) 251-0143 | |
Not Available |
Full Name | Rebecca Hoffman |
---|---|
Gender | Female |
Speciality | Allergy & Immunology |
Location | 1300 Elmwood Ave, Wilmette, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629489828 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 036071845 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rebecca Hoffman, MD 1300 Elmwood Ave, Wilmette, IL 60091-1649 Ph: (847) 251-0143 | Rebecca Hoffman, MD 1300 Elmwood Ave, Wilmette, IL 60091-1649 Ph: (847) 251-0143 |
News Archive
Ultromics is currently supporting multiple ongoing clinical trials including "Rainier", based in the U.S., and "EVAREST", in the UK.
A state of the art plenary session during the Pediatric Academic Societies (PAS) 2021 Virtual Meeting will bring together national experts on child poverty, racism and racial inequities, immigrant health, Native American culture, and environmental threats to discuss the intersectionality of child poverty.
Today's early morning highlights from the major news organizations, including a number of reports about congressional efforts to avert the "fiscal cliff."
Celldex Therapeutics, Inc. today reported financial results for the third quarter ended September 30, 2010. Celldex reported a net loss of $9.1 million, or $0.28 per share, for the third quarter of 2010 compared to a net loss of $7.2 million, or $0.45 per share, for the third quarter of 2009. For the nine months ended September 30, 2010, Celldex reported a net loss of $25.2 million, or $0.79 per share, compared to a net loss of $23.6 million, or $1.49 per share, for the nine months ended September 30, 2009.
The AUA is pleased to announce their new Guideline on the Management of Nonmuscle Invasive Bladder Cancer. Each year, more than 60,000 people are diagnosed with bladder cancer, which has been linked to a number of risk factors, including cigarette smoking and exposure to hazardous chemicals.
› Verified 8 days ago